Form 4: ENSG CEO Barry Port Granted Equity, Options

Sentiment:

Insider Transaction Report


Ensign Group CEO Barry Port received grants of 12,000 common shares and 30,000 employee stock options as part of a pre-planned compensation arrangement.

Summary

  • Barry Port, Chief Executive Officer and Director of Ensign Group, Inc. (ENSG), was granted 12,000 shares of common stock and 30,000 employee stock options on February 26, 2026.
  • The 12,000 common shares were acquired at a price of $0 and are scheduled to vest in five equal annual installments beginning February 26, 2027.
  • The 30,000 employee stock options have an exercise price of $212.65, an expiration date of February 26, 2036, and will also vest in five equal annual installments starting February 26, 2027.
  • Following these transactions, Port directly owns 82,352 common shares and 30,000 derivative securities (options), and indirectly owns 150,480 common shares through a trust.
  • These transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled compensation event.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal, as it represents a significant equity grant to the CEO, aligning his long-term incentives with shareholder value creation.

Positives

  • Grant of 12,000 common shares to the CEO, which aligns management's long-term interests with those of shareholders.
  • Grant of 30,000 employee stock options to the CEO, providing long-term incentives tied to the company's stock performance.
  • The transactions are part of a pre-planned Rule 10b5-1(c) plan, indicating structured and transparent compensation practices.

Future Outlook

The vesting schedules for the granted shares and options extend several years into the future, indicating a long-term incentive structure designed to retain the CEO and align his performance with the company's sustained growth.

Industry Context

StockSavvy.ai notes that equity grants and stock options are standard components of executive compensation packages in the healthcare services industry, designed to incentivize long-term performance and align executive interests with shareholder value creation.

Comparison to Industry Standards

  • StockSavvy.ai observes that the structure of these grants, with multi-year vesting schedules, is consistent with common executive compensation practices across publicly traded companies.
  • Peers in the skilled nursing and senior living sectors, such as Genesis Healthcare (GEN) or Brookdale Senior Living (BKD), also utilize equity-based incentives to retain and motivate key leadership.
  • The $0 acquisition price for the shares and options themselves (before exercise) is typical for grants of restricted stock or options as part of a compensation plan.

Stakeholder Impact

  • Shareholders: Potentially positive due to increased alignment of the CEO's interests with the company's long-term performance and value creation.

Next Steps

  • Vesting of 12,000 common shares in five equal annual installments beginning February 26, 2027.
  • Vesting of 30,000 employee stock options in five equal annual installments beginning February 26, 2027.

Key Dates

DateDescription
02/26/2026Date of grant for 12,000 common shares and 30,000 employee stock options.
03/02/2026Date the Form 4 was filed with the SEC.
02/26/2027Start date for the five equal annual vesting installments for both the common shares and employee stock options.
02/26/2036Expiration date for the employee stock options.

Recommendation

hold

The grant of equity and options to CEO Barry Port is a standard compensation practice that aligns management's long-term interests with shareholders. While positive for governance and incentive alignment, it does not represent a discretionary open-market purchase or sale that would warrant a change in investment recommendation based solely on this filing. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Ensign Group, ENSG, Barry Port, CEO, Director, stock grant, stock options, equity compensation, insider transaction, Form 4, Rule 10b5-1, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.